281 related articles for article (PubMed ID: 17117054)
1. Dialyzer fiber bundle volume during hemodialysis using large-surface dialyzers.
Leblanc M; Lafrance JP; Renald A
ASAIO J; 2006; 52(6):646-51. PubMed ID: 17117054
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of coagulation and anti-Xa factor when using a heparin-coated AN69ST® dialyser.
Sánchez-Canel JJ; Pons-Prades R; Salvetti ML; Seores A; Vázquez M; Pérez-Alba A; Tamarit E; Calvo-Gordo C; Villatoro J
Nefrologia; 2012; 32(5):605-12. PubMed ID: 23013946
[TBL] [Abstract][Full Text] [Related]
3. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
4. [Clinical usefulness of Nephral ST dialyzers in hemodialyzed patients with increased risk of bleeding].
Kopeć J; Sułowicz W
Przegl Lek; 2010; 67(2):91-4. PubMed ID: 20557006
[TBL] [Abstract][Full Text] [Related]
5. Vitamin E-Coated and Heparin-Coated Dialyzer Membranes for Heparin-Free Hemodialysis: A Multicenter, Randomized, Crossover Trial.
Islam MS; Hassan ZA; Chalmin F; Vido S; Berrada M; Verhelst D; Donnadieu P; Moranne O; Esnault VL
Am J Kidney Dis; 2016 Nov; 68(5):752-762. PubMed ID: 27344212
[TBL] [Abstract][Full Text] [Related]
6. The influence of dialyzer geometry on blood coagulation and biocompatibility.
Lins LE; Boberg U; Jacobson SH; Kjellstrand C; Ljungberg B; Skröder R
Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717
[TBL] [Abstract][Full Text] [Related]
7. Measurement of fiber bundle volume in reprocessed dialyzers.
Narsipur SS
Clin Nephrol; 2004 Feb; 61(2):130-3. PubMed ID: 14989633
[TBL] [Abstract][Full Text] [Related]
8. Dialyzer fiber bundle volume and kinetics of solute removal in continuous venovenous hemodialysis.
Liangos O; Sakiewicz PG; Kanagasundaram NS; Hammel J; Pajouh M; Seifert T; Paganini EP
Am J Kidney Dis; 2002 May; 39(5):1047-53. PubMed ID: 11979349
[TBL] [Abstract][Full Text] [Related]
9. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
[TBL] [Abstract][Full Text] [Related]
10. Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding.
Evenepoel P; Dejagere T; Verhamme P; Claes K; Kuypers D; Bammens B; Vanrenterghem Y
Am J Kidney Dis; 2007 May; 49(5):642-9. PubMed ID: 17472846
[TBL] [Abstract][Full Text] [Related]
11. [Clinical usefulness of heparin-coated dialyzers].
Kopeć J; Sułowicz W
Przegl Lek; 2014; 71(8):430-2. PubMed ID: 25546914
[TBL] [Abstract][Full Text] [Related]
12. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
Lavaud S; Canivet E; Wuillai A; Maheut H; Randoux C; Bonnet JM; Renaux JL; Chanard J
Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
[TBL] [Abstract][Full Text] [Related]
13. In vivo measurement of hemodialyzer fiber bundle volume: theory and validation.
Krivitski NM; Kislukhin VV; Snyder JW; MacGibbon DR; Kuznetsova OA; Reasons AM; Depner TA
Kidney Int; 1998 Nov; 54(5):1751-8. PubMed ID: 9844155
[TBL] [Abstract][Full Text] [Related]
14. Hemodialysis without heparin: a randomized, controlled, crossover study of two dialysis membranes (AN69ST and polysulfone F60).
Brunet P; Frances J; Vacher-Coponat H; Jaubert D; Lebrun G; Gondouin B; Duval A; Berland Y
Int J Artif Organs; 2011 Dec; 34(12):1165-71. PubMed ID: 22198602
[TBL] [Abstract][Full Text] [Related]
15. Biocompatibility of heparin-grafted hemodialysis membranes: impact on monocyte chemoattractant protein-1 circulating level and oxidative status.
Morena M; Jaussent I; Chalabi L; Bargnoux AS; Dupuy AM; Badiou S; Rakic C; Thomas M; Canaud B; Cristol JP; Michel F
Hemodial Int; 2010 Oct; 14(4):403-10. PubMed ID: 20955273
[TBL] [Abstract][Full Text] [Related]
16. The clinical evaluation of low-dose heparin in haemodialysis: a prospective study using the heparin-coated AN69 ST membrane.
Chanard J; Lavaud S; Maheut H; Kazes I; Vitry F; Rieu P
Nephrol Dial Transplant; 2008 Jun; 23(6):2003-9. PubMed ID: 18156457
[TBL] [Abstract][Full Text] [Related]
17. Effect of a sliding scale protocol for heparin on the ability to maintain whole blood activated partial thromboplastin times within a desired range in hemodialysis patients.
Low CL; Bailie G; Morgan S; Eisele G
Clin Nephrol; 1996 Feb; 45(2):120-4. PubMed ID: 8846524
[TBL] [Abstract][Full Text] [Related]
18. Improved dialyzer reuse after use of a population pharmacodynamic model to determine heparin doses.
Ouseph R; Brier ME; Ward RA
Am J Kidney Dis; 2000 Jan; 35(1):89-94. PubMed ID: 10620549
[TBL] [Abstract][Full Text] [Related]
19. A new synthetic dialyzer with advanced permselectivity for enhanced low-molecular weight protein removal.
Krieter DH; Lemke HD; Wanner C
Artif Organs; 2008 Jul; 32(7):547-54. PubMed ID: 18638309
[TBL] [Abstract][Full Text] [Related]
20. [Automatic re-utilization of capillary dialysis].
Szepietowski T; Uzar J
Polim Med; 1989; 19(3-4):107-18. PubMed ID: 2641400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
